{"@id":"https://bioecon.ru/technology/ai-protein-engineering/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://bioecon.ru/technology/ai-protein-engineering/","json":"https://bioecon.ru/api/v1/technology/ai-protein-engineering/index.json"},"id":"ai-protein-engineering","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/enzymicals-ag/","https://bioecon.ru/companies/21st-bio/","https://bioecon.ru/companies/turenscape/","https://bioecon.ru/companies/evogene/","https://bioecon.ru/companies/b-fab-gmbh/","https://bioecon.ru/companies/dyadic-international/","https://bioecon.ru/companies/imperagen/","https://bioecon.ru/companies/moolec-science/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/brevel/"]},"maturity":8,"name":"Генеративный ИИ-инжиниринг белков и оптимизация стабильности молекул","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Языковые модели для анализа последовательностей (pLM)"},{"n":2,"title":"Генеративный диффузионный 3D-дизайн остова"},{"n":3,"title":"Прогноз стабильности и мутаций in silico (zero-shot)"},{"n":4,"title":"Роботизированная лабораторная валидация"}],"summary":"Корпоративные платформы белкового инжиниринга на основе языковых моделей (pLM) и диффузионных нейросетей для дизайна новых белков и ферментов.","url":"/technology/ai-protein-engineering/","verified":"2026-11-22"}